![Sung Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 30/06/2026
Sung H.
Lee is currently Lead Independent Director at Tango Therapeutics, Inc. since 2026 and Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. since 2024.
Former positions include Vice President-Investor Relations at Gilead Sciences, Inc. from 2016 to 2019, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, Chief Financial Officer at MorphoSys AG from 2021 to 2023, and Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. from 2023 to 2024.
Education includes graduate studies at the University of Southern California and undergraduate studies at the University of California, Irvine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/07/2026 | 63.221 ( 0,05 % ) | 5 M $ | 30/06/2026 | |
TANGO THERAPEUTICS, INC. 0,02 % | 05/06/2026 | 22.870 ( 0,02 % ) | 714 916 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Director Financiero/CFO | 08/05/2024 |
| TANGO THERAPEUTICS, INC. | Director/Miembro de la Junta | 05/01/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director Financiero/CFO | 03/05/2024 |
| MORPHOSYS AG | Director Financiero/CFO | 17/03/2023 |
| SANGAMO THERAPEUTICS, INC. | Director Financiero/CFO | 01/02/2021 |
| GILEAD SCIENCES, INC. | Contacto de Relaciones con Inversores | 31/10/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
